News

VIDEO: Hepatologists on social media ‘play a very important role’

BOSTON — In this exclusive video from The Liver Meeting 2019, Elliot B. Tapper, MD, an assistant professor of gastroenterology at University of Michigan, highlights a session that discussed the risks and benefits of using social media, in particular Twitter.“Increasingly, we’re becoming involved in social media and we think that hepatologists play a very important…

News

Cirrhosis-related financial burden impairs liver cancer surveillance

BOSTON — Researchers found that health care financial burden was common in patients with cirrhosis and may be associated with lower receipt of hepatocellular carcinoma surveillance, according to a presenter at The Liver Meeting 2019.“The impetus of our study was prior data that suggested patients with cancer often report medical-related financial problems including high out-of-pocket…

News

Low risk for adverse cirrhosis events in pregnant women ‘reassuring’

BOSTON — In pregnant women with cirrhosis, less than 2% had liver decompensation within 1 year after delivery and the odds for decompensation were lower compared with women who were not pregnant with cirrhosis, according to data presented at The Liver Meeting 2019.“In North America over the past 5 years, it’s become apparent that there…

News

Novel machine learning model effectively predicts NASH

BOSTON — A machine learning approach demonstrated a relatively high sensitivity rate for predicting the probability of non-alcoholic steatohepatitis in at-risk patients, according to data presented at The Liver Meeting 2019.“I have been involved in NASH research for the last 15 years and one of the striking findings is the low awareness of the disease;…

News

Kratom-related liver injuries on the rise in the US

BOSTON — The commercially available botanical product kratom, often used for its psychotropic effects, was associated with several cases of liver injury, according to data presented at The Liver Meeting 2019.“We found that the frequency of kratom use is on the rise in the United States,” Victor J. Navarro, MD, FAASLD, medical director of liver…

News

Combination therapy prevents HCV infection in non-viremic organ recipients

BOSTON — Hepatitis C infection was prevented or rapidly cured in transplant recipients who received organs from donors infected with the virus following combined treatment with ezetimibe and direct-acting antiviral therapy, according to study results presented at The Liver Meeting 2019.“Unfortunately, most of you know that the opioid epidemic continues and, with that, an overdose…